Clinical Trial Update: A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating felzartamab infusions in adults with primary membranous nephropathy, and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy

Drugs mentioned

• Felzartamab (felzartamab)

Snippet

Sponsor: Biogen | Conditions: Primary Membranous Nephropathy | Phase 3 | Status: RECRUITING